Fused Imidazole Derivatives as IL-17 Modulators
A series of substituted fused bicyclic imidazole derivatives of formula (I), including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments including inflammatory and...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Horsley, Helen Tracey Haslett, Gregory William Taylor, Richard David Reuberson, James Thomas Chappell, Rose Elizabeth Smalley, Adam Peter Chu, Shuyu Monck, Nathaniel Julius Thomas Chovatia, Prafulkumar Tulshibhai Zhu, Zhaoning Brace, Gareth Neil |
| description | A series of substituted fused bicyclic imidazole derivatives of formula (I), including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments including inflammatory and autoimmune disorders, wherein i. a. A represents C-R1 or N; B represents C-R2 or N; D represents C-R3 or N; E represents C-R4 or N; Z represents -CH(R5)N(H)CH2R6, -CH(R5)N(H)S(O)2R6, -C(═CR5aR5b)N(H)C(O)R6, -CH(R5)R7, -CH(R5)N(H)R7 or -CH(R5)C(O)N(H)R7; R0 represents hydrogen or C1-6 alkyl. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2022242855A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2022242855A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2022242855A13</originalsourceid><addsrcrecordid>eNrjZNB3Ky1OTVHwzM1MSazKz0lVcEktyixLLMksSy1WSCxW8PTRNTRX8M1PKc1JLMkvKuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRkZGJkYWpqaOhsbEqQIAcHgq7Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Fused Imidazole Derivatives as IL-17 Modulators</title><source>esp@cenet</source><creator>Horsley, Helen Tracey ; Haslett, Gregory William ; Taylor, Richard David ; Reuberson, James Thomas ; Chappell, Rose Elizabeth ; Smalley, Adam Peter ; Chu, Shuyu ; Monck, Nathaniel Julius Thomas ; Chovatia, Prafulkumar Tulshibhai ; Zhu, Zhaoning ; Brace, Gareth Neil</creator><creatorcontrib>Horsley, Helen Tracey ; Haslett, Gregory William ; Taylor, Richard David ; Reuberson, James Thomas ; Chappell, Rose Elizabeth ; Smalley, Adam Peter ; Chu, Shuyu ; Monck, Nathaniel Julius Thomas ; Chovatia, Prafulkumar Tulshibhai ; Zhu, Zhaoning ; Brace, Gareth Neil</creatorcontrib><description>A series of substituted fused bicyclic imidazole derivatives of formula (I), including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments including inflammatory and autoimmune disorders, wherein i. a. A represents C-R1 or N; B represents C-R2 or N; D represents C-R3 or N; E represents C-R4 or N; Z represents -CH(R5)N(H)CH2R6, -CH(R5)N(H)S(O)2R6, -C(═CR5aR5b)N(H)C(O)R6, -CH(R5)R7, -CH(R5)N(H)R7 or -CH(R5)C(O)N(H)R7; R0 represents hydrogen or C1-6 alkyl.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220804&DB=EPODOC&CC=US&NR=2022242855A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220804&DB=EPODOC&CC=US&NR=2022242855A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Horsley, Helen Tracey</creatorcontrib><creatorcontrib>Haslett, Gregory William</creatorcontrib><creatorcontrib>Taylor, Richard David</creatorcontrib><creatorcontrib>Reuberson, James Thomas</creatorcontrib><creatorcontrib>Chappell, Rose Elizabeth</creatorcontrib><creatorcontrib>Smalley, Adam Peter</creatorcontrib><creatorcontrib>Chu, Shuyu</creatorcontrib><creatorcontrib>Monck, Nathaniel Julius Thomas</creatorcontrib><creatorcontrib>Chovatia, Prafulkumar Tulshibhai</creatorcontrib><creatorcontrib>Zhu, Zhaoning</creatorcontrib><creatorcontrib>Brace, Gareth Neil</creatorcontrib><title>Fused Imidazole Derivatives as IL-17 Modulators</title><description>A series of substituted fused bicyclic imidazole derivatives of formula (I), including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments including inflammatory and autoimmune disorders, wherein i. a. A represents C-R1 or N; B represents C-R2 or N; D represents C-R3 or N; E represents C-R4 or N; Z represents -CH(R5)N(H)CH2R6, -CH(R5)N(H)S(O)2R6, -C(═CR5aR5b)N(H)C(O)R6, -CH(R5)R7, -CH(R5)N(H)R7 or -CH(R5)C(O)N(H)R7; R0 represents hydrogen or C1-6 alkyl.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB3Ky1OTVHwzM1MSazKz0lVcEktyixLLMksSy1WSCxW8PTRNTRX8M1PKc1JLMkvKuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRkZGJkYWpqaOhsbEqQIAcHgq7Q</recordid><startdate>20220804</startdate><enddate>20220804</enddate><creator>Horsley, Helen Tracey</creator><creator>Haslett, Gregory William</creator><creator>Taylor, Richard David</creator><creator>Reuberson, James Thomas</creator><creator>Chappell, Rose Elizabeth</creator><creator>Smalley, Adam Peter</creator><creator>Chu, Shuyu</creator><creator>Monck, Nathaniel Julius Thomas</creator><creator>Chovatia, Prafulkumar Tulshibhai</creator><creator>Zhu, Zhaoning</creator><creator>Brace, Gareth Neil</creator><scope>EVB</scope></search><sort><creationdate>20220804</creationdate><title>Fused Imidazole Derivatives as IL-17 Modulators</title><author>Horsley, Helen Tracey ; Haslett, Gregory William ; Taylor, Richard David ; Reuberson, James Thomas ; Chappell, Rose Elizabeth ; Smalley, Adam Peter ; Chu, Shuyu ; Monck, Nathaniel Julius Thomas ; Chovatia, Prafulkumar Tulshibhai ; Zhu, Zhaoning ; Brace, Gareth Neil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2022242855A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Horsley, Helen Tracey</creatorcontrib><creatorcontrib>Haslett, Gregory William</creatorcontrib><creatorcontrib>Taylor, Richard David</creatorcontrib><creatorcontrib>Reuberson, James Thomas</creatorcontrib><creatorcontrib>Chappell, Rose Elizabeth</creatorcontrib><creatorcontrib>Smalley, Adam Peter</creatorcontrib><creatorcontrib>Chu, Shuyu</creatorcontrib><creatorcontrib>Monck, Nathaniel Julius Thomas</creatorcontrib><creatorcontrib>Chovatia, Prafulkumar Tulshibhai</creatorcontrib><creatorcontrib>Zhu, Zhaoning</creatorcontrib><creatorcontrib>Brace, Gareth Neil</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Horsley, Helen Tracey</au><au>Haslett, Gregory William</au><au>Taylor, Richard David</au><au>Reuberson, James Thomas</au><au>Chappell, Rose Elizabeth</au><au>Smalley, Adam Peter</au><au>Chu, Shuyu</au><au>Monck, Nathaniel Julius Thomas</au><au>Chovatia, Prafulkumar Tulshibhai</au><au>Zhu, Zhaoning</au><au>Brace, Gareth Neil</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Fused Imidazole Derivatives as IL-17 Modulators</title><date>2022-08-04</date><risdate>2022</risdate><abstract>A series of substituted fused bicyclic imidazole derivatives of formula (I), including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments including inflammatory and autoimmune disorders, wherein i. a. A represents C-R1 or N; B represents C-R2 or N; D represents C-R3 or N; E represents C-R4 or N; Z represents -CH(R5)N(H)CH2R6, -CH(R5)N(H)S(O)2R6, -C(═CR5aR5b)N(H)C(O)R6, -CH(R5)R7, -CH(R5)N(H)R7 or -CH(R5)C(O)N(H)R7; R0 represents hydrogen or C1-6 alkyl.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2022242855A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Fused Imidazole Derivatives as IL-17 Modulators |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T12%3A22%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Horsley,%20Helen%20Tracey&rft.date=2022-08-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2022242855A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |